Kaplan Fox & Kilsheimer & Thomson Reuters — Reuters
4 shared events · Importance 4 · Last updated Aug 25, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Regulatory
Kaplan Fox & Kilsheimer: Kaplan Fox filed a class action against Futu and is actively soliciting lead plaintiffs. It is one of several firms pursuing claims.
Thomson Reuters — Reuters: Thomson Reuters — Reuters published the initial report on the CSRC crackdown, which triggered the market reaction and subsequent litigation.
Jul 20, 2026 · 100 articles
Regulatory
Kaplan Fox & Kilsheimer: Kaplan Fox & Kilsheimer is also investigating Medline for potential securities law violations, adding to the legal pressure on the company.
Thomson Reuters — Reuters: Thomson Reuters — Reuters reported on the FDA warning letter, providing additional context that this was the second such action against Medline in two months.
Jul 15, 2026 · 21 articles
Regulatory
Kaplan Fox & Kilsheimer: Kaplan Fox & Kilsheimer is a law firm involved in the class action, representing investors.
Thomson Reuters — Reuters: News agency that reported on the crackdown, triggering stock declines.
Jun 26, 2026 · 306 articles
Regulatory
Kaplan Fox & Kilsheimer: Law firm that alerted investors to the class action lawsuit.
Thomson Reuters — Reuters: Published an article on the FDA staff concerns and the stock plunge, widely cited in lawsuits.
Jul 27, 2026 · 293 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how Kaplan Fox & Kilsheimer and Thomson Reuters — Reuters interact across events, view sentiment trends, and discover connected entities.
Open Dashboard